HomeInsightsMarket Capitalization

Market Capitalization of Jubilant Pharmova Ltd

Market Capitalization of Jubilant Pharmova Ltd

stocks purchased

₹ 38.0 Cr

Volume transacted

stocks purchased

318.7 K

stocks traded

Last Updated time: 15 Sep 15:30 PM

Image

Jubilant Pharmova Ltd

NSE: JUBLPHARMA

MARKETCAP

19017.23 crore

Last updated: 13 Sep 24

Key Highlights

  • The Market Cap of Jubilant Pharmova Ltd is ₹ 19017 crore as of 13 Sep 24.
  • The Market Cap of Jubilant Pharmova Ltd changed from ₹ 10580 crore on March 2019 to ₹ 9056 crore on March 2024 . This represents a CAGR of -2.56% over 6 years. .
  • The Latest Trading Price of Jubilant Pharmova Ltd is ₹ 1193 as of 13 Sep 15:30.

Historical Market Cap of Jubilant Pharmova Ltd

No data available

* All values are in crore

Company Fundamentals for Jubilant Pharmova Ltd

No data available

Image

Jubilant Pharmova Ltd

NSE: JUBLPHARMA

PRICE

1193.8

145.55 (13.89%)

stock direction

Last updated: 13 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Jubilant Pharmova Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

SWOT Analysis Of Jubilant Pharmova Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Jubilant Pharmova Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Jubilant Pharmova Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Jubilant Pharmova Ltd7919,017
Sun Pharmaceuticals Industries Ltd424,44,825
Divis Laboratories Ltd871,45,892
Cipla Ltd301,33,994
Torrent Pharmaceuticals Ltd691,16,950
Zydus Lifesciences Ltd271,12,547

Key Valuation Metric of Jubilant Pharmova Ltd

No data available

Historical P/E Ratio of Jubilant Pharmova Ltd

No data available

* All values are in %

Historical Revenue of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical EBITDA of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical Net Profit of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical Dividend Payout of Jubilant Pharmova Ltd

No data available

* All values are in %

About Jubilant Pharmova Ltd

  • Jubilant Pharmova Limited, (Formerly known as Jubilant Life Sciences Limited), is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
  • The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs.
  • The pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-Sterile Products through 6 US FDA approved manufacturing facilities in India, USA and Canada with a network of over 48 radiopharmacies in the USA.
  • The contract research and development segment provides drug discovery and development services as well as clinical data software and service solutions.

Jubilant Pharmova Ltd News Hub

News

Jubilant Pharmova gains as Washington unit gets VAI classification from USFDA

The United States Food & Drug Administration (USFDA) conducted an audit of the facility fr...

Read more

11 Sep 202410:52

News

Jubilant Pharmova Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, La Opala RG Ltd, AGI Greenpac Ltd and Gujarat Alkalies & Chemica...

Read more

09 Sep 202412:00

News

Volumes soar at Jubilant Pharmova Ltd counter

Alembic Pharmaceuticals Ltd, Doms Industries Ltd, EPL Ltd, Anand Rathi Wealth Ltd are amon...

Read more

09 Sep 202414:30

News

Jubilant Biosys signs and issues a put option offer to Pierre Fabre Laboratories

Jubilant Biosys Innovative Research Services,, Singapore (JBIRSPL), subsidiary of Jubilant...

Read more

16 Aug 202418:41

News

Volumes soar at Jubilant Pharmova Ltd counter

Firstsource Solutions Ltd, Adani Energy Solutions Ltd, Sapphire Foods India Ltd, Lloyds Me...

Read more

01 Aug 202414:30

News

Jubilant Pharmova hits 52-week high after Q1 PAT zooms to Rs 482 cr

Total income increased by 9.41% to Rs 1,745.7 crore in Q1 FY25 as compared with Rs 1,595.5...

Read more

19 Jul 202415:06

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Jubilant Pharmova Ltd

What is the market cap of Jubilant Pharmova Ltd?

As of September 15, 2024, Jubilant Pharmova Ltd has a market capitalization of ₹19017.23, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Jubilant Pharmova Ltd's market capitalization?

Jubilant Pharmova Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Jubilant Pharmova Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Jubilant Pharmova Ltd's market capitalization change?

Jubilant Pharmova Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*